World Thalassemia Day, observed annually on May 8th, is a significant date dedicated to raising awareness about Thalassemia, a genetic blood disorder. This occasion offers a chance to raise awareness about the struggles encountered by individuals with Thalassemia, stressing the significance of prompt diagnosis and effective disease management. It also underscores the vital requirement for accessible treatment choices and ongoing backing for research efforts to discover a cure.

The commemoration of World Thalassemia Day encourages a unified approach to improving the health and well-being of affected individuals, promoting the availability of better health services and care. This day is crucial in fostering a more informed and empathetic society toward thalassemia and its impacts through global solidarity and informed public initiatives.

Let us discuss different types of thalassemia and its treatment and prevention.

Types of Thalassemia

There are different types of thalassemia; the two major ones are -

Alpha Thalassemia - Alpha Thalassemia is of two types.
Alpha Thalassemia Minor—Also referred to as the Alpha thalassemia trait, this condition occurs when one or two alpha globin genes are missing. Patients with this condition experience mild anaemia.
Alpha Thalassemia Major- Also referred to as Haemoglobin H Disease, the patients have three mutated or missing alpha globin genes in this condition. This condition may lead the patient to moderate to severe anaemia. There may be other health complications, too.
Hydrops Fetalis - It is the most aggressive form of Alpha thalassemia, where all four alpha globins are either non-functional or missing. It results in severe anaemia in the foetus and is found to be fatal.
Beta Thalassemia—It is important to note that patients with one mutated beta globin gene usually have no symptoms or mild anaemia.
Beta Thalassemia Intermedia—Patients with Beta Thalassemia intermedia have two mutated beta globin genes. It may cause moderate to severe anaemia, but it is less severe than beta thalassemia major.
Beta Thalassemia Major—Also referred to as Cooley's Anaemia, this is the most severe form, in which both beta globin genes are mutated or missing. It leads to severe anaemia that requires lifelong blood transfusions and other treatments.

There are also other, less common variants and subtypes within these categories. The severity of thalassemia varies widely, from asymptomatic carriers to life-threatening conditions requiring constant medical care. Treatment usually involves blood transfusions, iron chelation therapy (to manage iron overload), and sometimes bone marrow transplantation.

Also Read - Thalassemia Causes and Symptoms

Treatment of Thalassemia

Blood Transfusions- Regular blood transfusions are a crucial treatment for moderate to severe Thalassemia ia, helping to maintain normal haemoglobin levels and red blood cell count. However, regular transfusions might cause iron overload in the body.
Iron Chelation Therapy—Patients often require iron chelation therapy to prevent iron overload from regular transfusions. This treatment involves medications that remove excess iron from the body, which can be administered orally or through injections.
Folic Acid Supplements—Although they don't directly treat thalassemia, folic acid supplements can help promote red blood cell production and are often recommended for patients.
Bone Marrow or Stem Cell Transplant- The sole potential remedy for Thalassemia involves transplanting bone marrow or stem cells from a suitable donor, typically more effective in young patients yet posing risks like graft-versus-host disease.
Gene Therapy- An emerging treatment, thalassemia therapy, aims to introduce genes that can produce normal haemoglobin into the patient's bone marrow cells. This approach is still largely experimental but has shown promise in clinical trials.
Surgery- In some cases, surgical removal of the spleen (splenectomy) may be necessary if the spleen becomes overly enlarged and starts to destroy red blood cells excessively.
Management of Complications- Patients need regular monitoring for complications like heart problems due to iron overload, bone deformities, and infections.

Prevention from Thalassemia

Thalassemia can be prevented using a combination of treatments such as prenatal screening and genetic counselling.

Genetic Counselling - Couples with a family history of thalassemia or who belong to ethnic groups at higher risk should consider genetic counselling before planning a pregnancy. These counsellors can assess the risk of passing on thalassemia and discuss options for family planning.
Prenatal Diagnosis - For couples at risk of having a child with thalassemia, prenatal diagnosis through techniques like chorionic villus sampling (CVS) or amniocentesis can be performed to detect the presence of thalassemia in the fetus. This allows parents to make informed decisions about pregnancy management and future options.
Carrier Screening - Individuals must undergo carrier screening before conceiving to determine if they carry thalassemia genes. Carrier screening can help identify couples at risk of having children with thalassemia major or other severe forms of the disease.
Pre-implantation Genetic Diagnosis (PGD) - Couples undergoing in vitro fertilisation (IVF) can opt for PGD, which involves testing embryos for thalassemia before implantation. This allows the selection of unaffected embryos for transfer, reducing the risk of having a child with thalassemia.

Conclusion

Thalassemia is a genetic blood disorder that disrupts normal haemoglobin production, which is crucial for oxygen transport in the body. Symptoms vary based on the type and severity but typically include fatigue, pale skin, facial bone deformities, growth delays, abdominal swelling, dark urine, and susceptibility to infections. Inherited in an autosomal recessive manner, the condition arises from mutations in haemoglobin genes, leading to decreased or abnormal haemoglobin levels.

Treatment prioritises symptom management and complication prevention, often involving standard methods like regular blood transfusions and iron chelation therapy to address anaemia and avoid iron overload. In severe instances, bone marrow or stem cell transplants may provide a potential cure, with emerging therapies like gene therapy holding promise for future interventions. Effectively managing Thalassemia demands personalised care, underscoring the need for consistent medical supervision to enhance quality of life.